|
ARIH1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.74370000006041E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.95370000000339E-05 |
| Normal-vs-Stage2 |
1.376540E-04 |
| Normal-vs-Stage3 |
5.68259999944587E-07 |
| Normal-vs-Stage4 |
6.41430000000165E-05 |
| Stage1-vs-Stage2 |
3.723600E-01 |
| Stage1-vs-Stage3 |
8.617800E-02 |
| Stage1-vs-Stage4 |
3.637400E-01 |
| Stage2-vs-Stage3 |
7.272200E-01 |
| Stage2-vs-Stage4 |
9.905200E-01 |
| Stage3-vs-Stage4 |
7.060000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.49989999997935E-06 |
| Normal-vs-AfricanAmerican |
1.065810E-01 |
| Normal-vs-Asian |
2.158100E-04 |
| Caucasian-vs-AfricanAmerican |
1.633960E-01 |
| Caucasian-vs-Asian |
7.784600E-01 |
| AfricanAmerican-vs-Asian |
1.693580E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.65545999999406E-05 |
| Normal-vs-Female |
1.34620000002972E-06 |
| Male-vs-Female |
8.755800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.198400E-04 |
| Normal-vs-Age(41-60Yrs) |
3.37599999955529E-07 |
| Normal-vs-Age(61-80Yrs) |
2.70499999999174E-06 |
| Normal-vs-Age(81-100Yrs) |
2.044400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.932200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.503220E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.702400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.370600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.178200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.419800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.163560E-01 |
| Classical-VS-Follicular |
1.741170E-03 |
| Classical-VS-Other |
2.438400E-01 |
| Classical-VS-Normal |
1.570990E-04 |
| Tall-VS-Follicular |
6.601000E-01 |
| Tall-VS-Other |
7.116600E-01 |
| Tall-VS-Normal |
2.241200E-04 |
| Follicular-VS-Other |
9.224000E-01 |
| Follicular-VS-Normal |
3.62059999980957E-07 |
| Other-VS-Normal |
1.737870E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.14200000251353E-08 |
| Normal-vs-N1 |
3.94110000000447E-05 |
| N0-vs-N1 |
8.722800E-01 |
|
|
